| Website | neurotechusa.com |
| Category | BioTech |
| Phone | 401-333-3880 |
| contact@neurotech... | |
| Employees |
| TOTAL | $35M |
| FUNDING TOTAL | $35M |
| Series B, 11/06 Burrill & Company Versant Ventures SV Life Sciences Omega Funds Nexus Medical Partners Pound Capital Apax Partners Merlin Biosciences Atlas Venture Mayflower Avida Group Alpha Associates | $35M |
Neurotech is a privately held biotechnology company developing sight-saving therapeutics for chronic retinal diseases—including indications with significant unmet medical need that, as a whole, represent the largest market opportunity in ophthalmology.
